{
    "SPADE_UN_13420": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13420",
            "Peptide Name": "[P5K,D9K]Hymenochirin-1B",
            "Source": "Synthetic construct",
            "Family": "N/A",
            "Gene": "N/A",
            "Sequence": "IKLSKETKKNLKKVLKGAIKGAIAVAKMV",
            "Sequence Length": 29,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notfound"
            ],
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer"
            ],
            "Target Organism": "[Ref.24172540] Gram-positive bacteria:S. aureus ATCC 29213 (MIC = 6.25 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 1.6 μM), C.albicans ATCC 90028 (MIC = 50 μM);Gram-negative bacteria:E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 12.5 μM), P.mirabilis (MIC > 100 μM).[Ref.30789695] Cancer cell lines:A549 (IC50 = 1.17 ± 0.23 μM), HCT116 (IC50 = 4.93 ± 0.51 μM), HepG2 (IC50 = 2.46 ± 0.32 μM).",
            "Hemolytic Activity": "[Ref.24172540] LC₅₀ = 127 ± 9 μM against freshly prepared human erythrocytes.",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "No structure indentification experiment and detailed structure description found",
            "Formula": "C142H263N39O35S",
            "Mass": 3108.91,
            "PI": 10.54,
            "Net Charge": 8,
            "Hydrophobicity": 0.08,
            "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.",
            "Comments": "Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays",
            "Literature": [
                {
                    "Title": "An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties.",
                    "Pubmed ID": "24172540",
                    "Reference": "Peptides. 2013 Dec;50153-9. doi 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.",
                    "Author": "Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24172540"
                },
                {
                    "Title": "Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B A Nov",
                    "Pubmed ID": "30789695",
                    "Reference": "ACS Chem Biol. 2019 Mar 15;14(3)516-525. doi 10.1021/acschembio.9b00046. Epub 2019 Mar 1.",
                    "Author": "Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30789695"
                },
                {
                    "Title": "Anti-tumor activities of the host-defense peptide hymenochirin-1B",
                    "Pubmed ID": "",
                    "Author": "Attoub S, Arafat K, Mechkarska M, Conlon JM"
                },
                {
                    "Title": "An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties",
                    "Pubmed ID": "",
                    "Author": "Mechkarska M, Prajeep M, Radosavljevic GD, Jovanovic IP, Al Baloushi A, Sonnevend A, Lukic ML, Conlo"
                }
            ],
            "Frequent Amino Acids": "KAI",
            "Absent Amino Acids": "CDFHOPQRUWY",
            "Basic Residues": 9,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 14,
            "Polar Residues": 19,
            "Positive Residues": 9,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_23805",
                    "Similarity": 1.0,
                    "Sequence": "IKLSKTKKLKKVLKGAIKGAIAVAKMV"
                },
                {
                    "SPADE_ID": "SPADE_UN_23807",
                    "Similarity": 1.0,
                    "Sequence": "IKLSKETKKNLKKVLKGAIKGIAVKMV"
                },
                {
                    "SPADE_ID": "SPADE_UN_23809",
                    "Similarity": 1.0,
                    "Sequence": "IKLSKTKKLKKVLKGIKGIAVAKMV"
                }
            ]
        }
    }
}